Rosanne M. Kho, MD
Primary Location
Cleveland Clinic Main Campus
- Appointment:
- 216.444.6601
- Desk:
- 216.444.6878
- Fax:
- 216.636.5129
Treatment & Services
- Excisions
- Hysterectomy
- Hysteroscopic Myomectomy
- Laparoscopic Assisted Vaginal Hysterectomy
- Robotic assisted gynecologic surgery
Specialty in Diseases & Conditions
- Abnormal Menstrual Bleeding
- Abnormal Uterine Bleeding
- Endometriosis
- Fibroids And Leiomyoma
- Ovarian Cysts
- Pelvic Disorders
- Uterine Fibroids
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Rosanne M. Kho, MD
Dr. Kho's clinical and academic work has focused on advancing vaginal and minimally invasive surgery. She was involved in the early adoption of robotics in gynecology during her fellowship training that has lead to multiple publications evaluating the appropriate application of the technology in the field. She is a strong advocate of the vaginal approach for benign hysterectomy and is recognized for her passion to bring vaginal surgery back into the armamentarium of the gynecologic surgeon. In recognition of her expertise in vaginal surgery, she was the Donald Richardson Memorial Lecture Speaker for ACOG ACM in April 2014. Recently, she developed an online module on the essentials of vaginal hysterectomy in collaboration with AAGL, ACOG and SGS. In addition to speaking on these topics, she has participated in live surgeries nationally and internationally demonstrating the applications of robotics and vaginal surgery in gynecology. Dr. Kho is published in the field of gynecologic surgery having authored many peer-reviewed articles and book chapters. She serves as a Senior Editor for Journal of Minimally Invasive Gynecology.
She served as President of the AAGL/SRS Fellowship Board in MIGS in 2015 where she led the efforts to revamp and standardize the requirements and goals of Fellowship training. She has also spearheaded the process of seeking Focused-Practice recognition from ABOG for Advanced Benign Surgery in Gynecology. These efforts are intended to ultimately elevate the training and quality of surgical care for women with benign conditions.
Dr. Kho has a great interest in teaching trainees in the residency and fellowship levels. She has also conducted multiple CME programs and hands-on workshops for national meetings. In recognition of her presentation skills and teaching, she received an award for Top Faculty of the Year (one of two recipients) in 2009 and Top Speaker of the Year in 2007 and 2008 (as one of 10 annual recipients) from the CME department at the Mayo Clinic. Dr. Kho also directed the first cadaveric workshop in vaginal hysterectomy for the annual AAGL Congress in 2012 and for ACOG ACM in 2014.
Since 2002, Dr. Kho has been involved in medical missions. She organizes surgical teams and travels to remote areas including Central Mexico and Brazil annually to teach and provide women the benefits of the minimally invasive approach.
Education & Professional Highlights
Appointed
2016
Education & Fellowships
Fellowship - Mayo Clinic
Female Pelvic Medicine & Reconstructive Surgery
Phoenix,
AZ USA
2007
Residency - Mayo Clinic
OB/GYN
Rochester,
MN USA
1996
Medical Education - Tulane University School of Public Health and Tropical Medicine
New Orleans,
LA USA
1992
Undergraduate - Santa Clara University
Psychology
Santa Clara,
CA USA
1988
Certifications
- Obstetrics and Gynecology
- Obstetrics and Gynecology - Female Pelvic Medicine and Reconstructive Surgery
Research & Publications
See publications for Rosanne M. Kho, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/2/2020, Dr. Kho has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
